The FDA granted fast track designation to KT-621 for treating patients with moderate to severe eosinophilic asthma, according ...
A new study by researchers at Fox Chase Cancer Center focusing on pancreatic cancer has shown that a new scoring system can ...
Researchers at Pennington Biomedical Research Center provide critical insight into how the brain and body work together to ...
EO1001 demonstrates up to ~40-fold greater potency than osimertinib in EGFR ECD-mutant tumor models EO4426 (tezacitabine) demonstrates selective targeting of DNA replication machinery and resistance ...
BH-501284 demonstrated high potency (median IC50 of 0.83 nM) and prolonged residence time (>54 hours) in KRAS-mutant cell lines, offering ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
New research finds a new strategy for treating a deadly cancer by combining existing drugs to indirectly weaken tumor growth, ...
CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Cells are enveloped by a lipid membrane that gives them structure and provides a barrier between the cell and its environment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results